Synapse - Adult Leukemia

Search Within

Adult Leukemia

Results (3720)

Drugging chromatin in cancer: Recent advances and novel approaches

Journal Article

Cai, S. F.; Chen, C. W.; Armstrong, S. A.
Molecular Cell (2015)

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: A long-term follow-up study of the US intergroup phase III trial E2997

Journal Article

Lucas, D. M.; Ruppert, A. S.; Lozanski, G.; Dewald, G. W.; Lozanski, A.; Claus, R.; Plass, C.; Flinn, I. W.; Neuberg, D. S.; Paietta, E. M.; more...
Leukemia and Lymphoma (2015)

Fulltext@MSK | Save

Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms

Journal Article

Molenaar, R. J.; Thota, S.; Nagata, Y.; Patel, B.; Clemente, M.; Przychodzen, B.; Hirsh, C.; Viny, A. D.; Hosano, N.; Bleeker, F. E.; more...
Leukemia (2015)

Fulltext@MSK | Save

CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: Limited graft-versus-host disease without increased relapse

Journal Article

Tamari, R.; Chung, S. S.; Papadopoulos, E. B.; Jakubowski, A. A.; Hilden, P.; Devlin, S. M.; Goldberg, J. D.; Perales, M. A.; Ponce, D. M.; Sauter, C. S.; more...
Biology of Blood and Marrow Transplantation (2015)

Fulltext@MSK | Save

Elevated blood pressure (BP) and adverse events of hypertension (HTN) in phase 1, 2, and 3 trials of ponatinib in leukemia

Meeting Abstract

Guilhot, F.; Khoury, H. J.; Baccarani, M.; Hochhaus, A.; Hughes, T. P.; Lipton, J. H.; Lustgarten, S.; Yanase, K.; Conlan, M. G.; Cortes, J. E.; more...
Haematologica (2015)

Fulltext@MSK | Save

Simulation in continuing education: Improving hematologist evidence-based decisions for myeloproliferative neoplasm management

Meeting Abstract

Van Laar, E.; Blevins, D.; Levine, R.; Mesa, R.
Haematologica (2015)

Fulltext@MSK | Save

Cardiovascular (CV)-related hospitalization in patients with chronic-phase chronic myeloid leukemia (CP-CML) in SIMPLICITY, a prospective observational study

Meeting Abstract

Paquette, R.; Mauro, M.; Simonsson, B.; Abruzzese, E.; Andorksy, D.; Hansen, R.; Subar, M.; Turner, M.; Zyczynski, T.; Mohamed, H.; more...
Haematologica (2015)

Fulltext@MSK | Save

Cardiovascular (CV) and pulmonary adverse events (AES) in patients (PTS) treated with BCR-ABL tyrosine kinase inhibitors (TKIS): Updated analysis from the FDA Adverse Event Reporting System (FAERS)

Meeting Abstract

Cortes, J.; Mauro, M.; Steegmann, J. L.; Saglio, G.; Soitkar, A.; Wallis, N.
Haematologica (2015)

Fulltext@MSK | Save

Ag-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies

Meeting Abstract

DiNardo, C.; Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; more...
Haematologica (2015)

Fulltext@MSK | Save

Clinical safety and activity of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a phase 1 study of patients with advanced IDH1-mutant hematologic malignancies

Meeting Abstract

de Botton, S.; Pollyea, D. A.; Stein, E. M.; DiNardo, C.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I.; Altman, J. K.; more...
Haematologica (2015)

Fulltext@MSK | Save